Health Technology Assessment

The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis

  • Type:
    Extended Research Article
  • Authors:
    Symmons D, Tricker K, Roberts C, Davies L, Dawes P, et al.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 9, Issue: 34
  • Published:
  • Citation:
    Symmons D, Tricker K, Roberts C, Davies L, Dawes P, et al. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technol Assess 2005;9(34). https://doi.org/10.3310/hta9340
  • DOI:
    https://doi.org/10.3310/hta9340
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates